Because A2M rose yesterday while BAL fell. A2M good news normally followed by BAL good news as the infant formula industry for Australia and NZ as a whole tends to move together.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come